<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04860687</url>
  </required_header>
  <id_info>
    <org_study_id>ODISSEA 1.0</org_study_id>
    <nct_id>NCT04860687</nct_id>
  </id_info>
  <brief_title>Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study.</brief_title>
  <acronym>ODISSEA</acronym>
  <official_title>Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Sanitaria-Universitaria Integrata di Udine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Sanitaria-Universitaria Integrata di Udine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute respiratory insufficiency is one of the principal causes of intensive care admission&#xD;
      for COVID 19 positive patients. This may determine a variable mortality rate ranging from&#xD;
      25-30%.&#xD;
&#xD;
      In these patients, many days of non-invasive or invasive mechanical ventilation are needed to&#xD;
      correct severe hypoxemia.&#xD;
&#xD;
      Mechanical ventilation is not a direct therapy but allows the clinicians to prolong the&#xD;
      &quot;time-to-recovery&quot; interval necessary for COVID 19 respiratory insufficiency treatment.&#xD;
&#xD;
      Long intensive care stay, mechanical ventilation, the use of steroids and sedatives have an&#xD;
      impact on the survivors.&#xD;
&#xD;
      Previous studies demonstrated that patients admitted to intensive care with non-COVID acute&#xD;
      respiratory distress syndrome had a reduction in the quality of life even up to one year&#xD;
      after discharge.&#xD;
&#xD;
      The aim of this study is to understand if COVID-19 related acute respiratory distress&#xD;
      syndrome has a worse impact on the quality of life one year after discharge when compared&#xD;
      with non-COVID-19 acute respiratory distress syndrome.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Short Form Health Survey 36</measure>
    <time_frame>One year after discharge</time_frame>
    <description>Evaluate the physical abilities of patients discharged from the intensive care unit after admission for COVID-19 respiratory insufficiency. The scale ranges from 0 to 100, where 0 is the worse value and 100 is the best.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of Event Scale - Revised (IES-R)</measure>
    <time_frame>One year after discharge</time_frame>
    <description>Identify post traumatic stress disorder in patients discharged from the intensive care unit after admission for COVID-19 respiratory insufficiency. The scale ranges from 0 to 88, where 0 is the best value and 88 the worst.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Age</measure>
    <time_frame>One year after discharge</time_frame>
    <description>Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the age of the patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gender</measure>
    <time_frame>One year after discharge</time_frame>
    <description>Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the gender of the patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scholarship</measure>
    <time_frame>One year after discharge</time_frame>
    <description>Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the scholarship of the patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Marital status</measure>
    <time_frame>One year after discharge</time_frame>
    <description>Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the marital status of the patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Steroids</measure>
    <time_frame>One year after discharge</time_frame>
    <description>Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the use of steroids</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle relaxants</measure>
    <time_frame>One year after discharge</time_frame>
    <description>Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the use of muscle relaxants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal replacement therapy</measure>
    <time_frame>One year after discharge</time_frame>
    <description>Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the use of renal replacement therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tracheostomy</measure>
    <time_frame>One year after discharge</time_frame>
    <description>Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with tracheostomy</description>
  </secondary_outcome>
  <enrollment type="Anticipated">309</enrollment>
  <condition>Covid19</condition>
  <condition>Post Traumatic Stress Disorder</condition>
  <condition>Quality of Life</condition>
  <eligibility>
    <study_pop>
      <textblock>
        COVID 19 positive patients admitted to the intensive care unit&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients discharged from the intensive care unit after admission for COVID-19&#xD;
             respiratory insufficiency that requested non-invasive or invasive mechanical&#xD;
             ventilation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of dementia&#xD;
&#xD;
          -  history of behavior disorders&#xD;
&#xD;
          -  pre-existing tracheostomy&#xD;
&#xD;
          -  advanced oncologic disease&#xD;
&#xD;
          -  end-stage-organ disease (dialysis, or enlisted for organ transplantation)&#xD;
&#xD;
          -  no consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Luigi Vetrugno, MD</last_name>
    <phone>+ 39 0432559509</phone>
    <email>luigi.vetrugno@asufc.sanita.fvg.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Anesthesia and Intensive Care, Academic Hospital of Catanzaro</name>
      <address>
        <city>Catanzaro</city>
        <state>Calabria</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Federico Longhini, MD,AP</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Anesthesia, Intensive Care and Pain Therapy, Academic Hospital &quot;Federico II&quot; of Naples</name>
      <address>
        <city>Naples</city>
        <state>Campania</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Vargas, MD, AP</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Anesthesia and Intensive Care, Academic Hospital of Ferrara</name>
      <address>
        <city>Ferrara</city>
        <state>Emilia Romagna</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Savino Spadaro, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Anesthesia and Intensive Care 2, Academic Hospital of Parma</name>
      <address>
        <city>Parma</city>
        <state>Emilia Romagna</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Giovanna Bignami, MD,FP</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Anesthesia and Intensive Care Department, Ravenna Hospital</name>
      <address>
        <city>Ravenna</city>
        <state>Emilia Romagna</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gianluca Zani, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Anesthesia and Intensive Care, Academic Hospital of Udine</name>
      <address>
        <city>Udine</city>
        <state>Friuli Venezia Giulia</state>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristian Deana, MD</last_name>
      <phone>+390432552410</phone>
      <email>cristian.deana@asufc.sanita.fvg.it</email>
    </contact>
    <investigator>
      <last_name>Luigi Vetrugno, MD,AP</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amato De Monte, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Flavio Bassi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tiziana Bove, MD,AP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesco Meroi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Anesthesia and Intensive Care 1, Hospital of Trento</name>
      <address>
        <city>Trento</city>
        <state>Trentino Alto Adige</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sergio Lassola, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Anesthesia and Intensive Care 2, Perugia Hospital</name>
      <address>
        <city>Perugia</city>
        <state>Umbria</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Edoardo De Robertis, MD,AP</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. Erratum in: JAMA. 2021 May 25;325(20):2120.</citation>
    <PMID>32250385</PMID>
  </reference>
  <reference>
    <citation>Azoulay É, Thiéry G, Chevret S, Moreau D, Darmon M, Bergeron A, Yang K, Meignin V, Ciroldi M, Le Gall JR, Tazi A, Schlemmer B. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore). 2004 Nov;83(6):360-370. doi: 10.1097/01.md.0000145370.63676.fb.</citation>
    <PMID>15525848</PMID>
  </reference>
  <reference>
    <citation>Thiéry G, Azoulay E, Darmon M, Ciroldi M, De Miranda S, Lévy V, Fieux F, Moreau D, Le Gall JR, Schlemmer B. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol. 2005 Jul 1;23(19):4406-13.</citation>
    <PMID>15994150</PMID>
  </reference>
  <reference>
    <citation>Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, Camporota L. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.</citation>
    <PMID>32291463</PMID>
  </reference>
  <reference>
    <citation>Vetrugno L, Bove T, Orso D, Barbariol F, Bassi F, Boero E, Ferrari G, Kong R. Our Italian experience using lung ultrasound for identification, grading and serial follow-up of severity of lung involvement for management of patients with COVID-19. Echocardiography. 2020 Apr;37(4):625-627. doi: 10.1111/echo.14664. Epub 2020 Apr 15. Review.</citation>
    <PMID>32239532</PMID>
  </reference>
  <reference>
    <citation>Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS; Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003 Feb 20;348(8):683-93.</citation>
    <PMID>12594312</PMID>
  </reference>
  <reference>
    <citation>Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol. 1998 Nov;51(11):1025-36.</citation>
    <PMID>9817120</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 22, 2021</study_first_submitted>
  <study_first_submitted_qc>April 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Sanitaria-Universitaria Integrata di Udine</investigator_affiliation>
    <investigator_full_name>Luigi Vetrugno</investigator_full_name>
    <investigator_title>Clinical Professor in Anesthesiology and Intensive Care</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

